G. H. Theilen

2.0k total citations
60 papers, 1.6k citations indexed

About

G. H. Theilen is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, G. H. Theilen has authored 60 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Genetics, 21 papers in Pulmonary and Respiratory Medicine and 20 papers in Immunology. Recurrent topics in G. H. Theilen's work include Virus-based gene therapy research (33 papers), Veterinary Oncology Research (21 papers) and T-cell and Retrovirus Studies (16 papers). G. H. Theilen is often cited by papers focused on Virus-based gene therapy research (33 papers), Veterinary Oncology Research (21 papers) and T-cell and Retrovirus Studies (16 papers). G. H. Theilen collaborates with scholars based in United States, Switzerland and Germany. G. H. Theilen's co-authors include S. P. Snyder, D. L. Dungworth, Debby Gould, Murray E. Fowler, Niels C. Pedersen, H. Lutz, Bruce R. Madewell, Robert J. Munn, Russell K. Durbin and N. C. Pedersen and has published in prestigious journals such as Nature, JNCI Journal of the National Cancer Institute and Annals of the New York Academy of Sciences.

In The Last Decade

G. H. Theilen

55 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. H. Theilen United States 19 836 458 413 314 297 60 1.6k
W. F. Robinson Australia 26 539 0.6× 203 0.4× 504 1.2× 293 0.9× 273 0.9× 73 1.8k
Gordon H. Theilen United States 18 497 0.6× 264 0.6× 350 0.8× 166 0.5× 351 1.2× 35 1.1k
Sandra L. Quackenbush United States 22 602 0.7× 501 1.1× 538 1.3× 336 1.1× 165 0.6× 60 1.7k
C. Olson United States 21 409 0.5× 732 1.6× 483 1.2× 261 0.8× 249 0.8× 76 1.7k
B. O'Neil United Kingdom 20 380 0.5× 556 1.2× 952 2.3× 227 0.7× 222 0.7× 27 1.5k
O. Jarrett United Kingdom 21 700 0.8× 243 0.5× 596 1.4× 103 0.3× 102 0.3× 38 1.2k
Padman S. Sarma United States 28 1.5k 1.8× 771 1.7× 851 2.1× 668 2.1× 100 0.3× 79 2.6k
L. Dmochowski United States 23 572 0.7× 399 0.9× 358 0.9× 389 1.2× 101 0.3× 169 1.6k
Israel Dvoretzky United States 12 607 0.7× 271 0.6× 592 1.4× 441 1.4× 49 0.2× 26 1.3k
Alfred B. Jenson United States 20 533 0.6× 453 1.0× 1.0k 2.5× 404 1.3× 210 0.7× 37 1.9k

Countries citing papers authored by G. H. Theilen

Since Specialization
Citations

This map shows the geographic impact of G. H. Theilen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. H. Theilen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. H. Theilen more than expected).

Fields of papers citing papers by G. H. Theilen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. H. Theilen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. H. Theilen. The network helps show where G. H. Theilen may publish in the future.

Co-authorship network of co-authors of G. H. Theilen

This figure shows the co-authorship network connecting the top 25 collaborators of G. H. Theilen. A scholar is included among the top collaborators of G. H. Theilen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. H. Theilen. G. H. Theilen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rabin, Harvey, et al.. (2015). Continuing Studies of Feline Sarcoma Virus-Induced Tumors in Nonhuman Primates. Proceedings of the International Symposium on Comparative Leukemia Research. 39. 244–250.
2.
Pedersen, Niels C., et al.. (2012). The effects of dog breed development on genetic diversity and the relative influences of performance and conformation breeding. Journal of Animal Breeding and Genetics. 130(3). 236–248. 35 indexed citations
3.
Rowe, Joan D., N. E. East, C. E. Franti, et al.. (1992). Risk factors associated with the incidence of seroconversion to caprine arthritis-encephalitis virus in goats on California dairies. American Journal of Veterinary Research. 53(12). 2396–2403. 40 indexed citations
5.
Pedersen, N. C., et al.. (1985). The nature of immunity to Snyder-Theilen fibrosarcoma virus induced tumors in cats. Veterinary Immunology and Immunopathology. 9(3). 283–300. 3 indexed citations
7.
Mathys, Alexander, Richard A. Mueller, N. C. Pedersen, & G. H. Theilen. (1983). Comparison of hemagglutination and competitive enzyme-linked immunosorbent assay procedures for detecting canine parvovirus in feces. American Journal of Veterinary Research. 44(1). 152–154. 13 indexed citations
8.
Lutz, H., Niels C. Pedersen, Russell K. Durbin, & G. H. Theilen. (1983). Monoclonal antibodies to three epitopic regions of feline leukemia virus p27 and their use in enzyme-linked immunosorbent assay of p27. Journal of Immunological Methods. 56(2). 209–220. 144 indexed citations
9.
Hunsmann, Gerhard, et al.. (1983). Active immunization with feline leukemia virus envelope glycoprotein suppresses growth of virus-induced feline sarcoma. Medical Microbiology and Immunology. 171(4). 233–241. 16 indexed citations
10.
Lutz, Holly L., et al.. (1980). Detection of feline leukemia virus infection.. 10(4). 13–23. 12 indexed citations
11.
Weller, Richard E., et al.. (1980). Chemoimmunotherapy for Canine Lymphosarcoma; A Prospective Evaluation of Specific and Nonspecific Immunomodulation. American Journal of Veterinary Research. 41(4). 516–521. 21 indexed citations
12.
Ruppanner, R., et al.. (1978). Comparison of Production Variables of Bovine Leukemia Virus Antibody-Negative and Antibody-Positive Cows in Two California Dairy Herds. American Journal of Veterinary Research. 39(7). 1093–1098. 28 indexed citations
13.
Theilen, G. H., et al.. (1977). Clinical Investigation of Doxorubicin, Daunomycin, and 6-Thioguanine in Normal Cats. American Journal of Veterinary Research. 38(4). 521–524. 3 indexed citations
14.
Hall, Judith G., Roland Scollay, M. S. C. Birbeck, & G. H. Theilen. (1975). Studies on FeSV induced sarcomata in sheep with particular reference to the regional lymphatic system. British Journal of Cancer. 32(6). 639–659. 5 indexed citations
15.
Theilen, G. H., et al.. (1974). Tumours induced in sheep by injecting cells transformed in vitro with feline sarcoma virus.. PubMed. 17(1). 152–5. 5 indexed citations
16.
Theilen, G. H.. (1971). Continuing Studies with Transmissible Feline Fibrosarcoma Virus in Fetal and Newborn Sheep. Journal of the American Veterinary Medical Association. 158(6). 1040–1045. 2 indexed citations
17.
Schalm, O. W. & G. H. Theilen. (1970). Myeloproliferative Disease in the Cat, Associated with C-Type Leukovirus Particles in Bone Marrow. Journal of the American Veterinary Medical Association. 157(11). 1686–1696. 9 indexed citations
18.
Snyder, S. P. & G. H. Theilen. (1969). Transmissible Feline Fibrosarcoma. Nature. 221(5185). 1074–1075. 161 indexed citations
19.
Theilen, G. H. & D. L. Dungworth. (1965). BOVINE LYMPHOSARCOMA IN CALIFORNIA. 3. THE CALF FORM.. PubMed. 26. 696–709. 20 indexed citations
20.
Theilen, G. H., et al.. (1962). Lymphosarcoma (lymphocytic leukemia) in the horse.. PubMed. 140. 923–30. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026